Interestingly, DVL2 protein levels were significantly higher in all subtypes of breast cancer compared to benignbreast tissues and the highest expression levels were found in HER2+ tumors compared to other subtypes of breast cancer, Luminal and TNBC (Fig. 1C). This evidence concerns the gene DVL2 and breast carcinoma.